BDR Pharma launches Nilotinib to treat PH+ leukemia EP News Bureau Jul 5, 2023 PH+ Leukemia, encompassing Acute Lymphoblastic Leukemia (ALL) and Chronic Myeloid Leukemia (CML) are infrequent and complex types…
